menu search

Roche: lower guidance in 2023, but positive trajectory

Roche P/E is discounted vs its historical average. All in all, Roche maintained its growth path with sales up 1% to CHF 63.28 billion. Looking at the ...

February 2, 2023, 11:14 pm

Ihe: a top-heavy pharma etf that's more average than outstanding

IHE tracks the Dow Jones U.S. Select pharmaceuticals Total Return Index, which invests solely in U.S. <...

February 2, 2023, 6:07 pm

There's a crop of great biotech companies ready to be acquired, says mpm's christiana bardon

Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the ...

February 2, 2023, 3:15 pm

Pharma earnings: covid β€˜is highly uncertain for this year,' analyst says

Pharma Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live anchors Rachelle Akuffo and Anjalee Khemlani to discuss ...

February 2, 2023, 2:36 pm

Biondvax presenting at bio ceo & investor conference

JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax pharmaceuticals Ltd . ( Nasd...

February 2, 2023, 2:15 pm

Reneo pharmaceuticals to participate in svb securities global biopharma conference

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) β€” Reneo pharmaceuticals, Inc. (NASDAQ: RPHM), a clinic...

February 2, 2023, 12:35 pm

Astrazeneca: will pharma giant beat revenue expectations?

AstraZeneca PLC (LSE:AZN) is poised to release its full-year results for 2022 on February 9, with shareholders hoping for the ...

February 2, 2023, 9:56 am

Eli lilly's stock falls after q4 revenue miss

Eli Lilly & Co.'s LLY, -0.46% stock fell 2.3% before market open Thursday after the biopharmaceutical g...

February 2, 2023, 7:18 am

Eli lilly stock falls even as earnings crush estimates

The pharmaceutical group reports earnings of $2.09 a share in the fourth quarter on revenue of $7.3 bil...

February 2, 2023, 7:03 am

Sage therapeutics to report fourth quarter and full year 2022 financial results on thursday, february 16, 2023

CAMBRIDGE, Mass.--( BUSINESS WIRE )--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical compan...

February 2, 2023, 6:30 am

West to host fourth-quarter and full-year 2022 conference call and announces participation in upcoming investor conferences

EXTON, Pa., Feb. 2, 2023 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global leade...

February 2, 2023, 6:00 am

Time to buy cigna or regeneron stock before earnings?

Among the Finance and Medical sector, Cigna (CI) and Regeneron pharmaceuticals (REGN) are both leaders ...

February 1, 2023, 8:19 pm

Vanda pharmaceuticals to announce fourth quarter and full year 2022 financial results on february 8, 2023

Conference Call and Webcast to Follow WASHINGTON , Feb. 1, 2023 /PRNewswire/ -- Vanda pharmaceuticals I...

February 1, 2023, 6:30 pm

Blister and other high visibility packaging consumption snowballing owing to rapidly increasing usage in food industry: fact.mr report

The Global Blister And Other High Visibility Packaging Market Is Projected To Profit From The Rapidly Growing Food And ...

February 1, 2023, 3:30 pm

3 sorry pharma stocks to sell in february before it's too late

pharmaceutical stocks have been relatively subdued in the last 12 months. During this period, the S&P 5...

February 1, 2023, 1:55 pm

Onl therapeutics receives u.s. fda clearance of investigational new drug application for onl1204 ophthalmic solution

First-in-class small molecule Fas inhibitor with unique mechanism of action is designed to provide neuroprotection for retinal cells ANN ARBOR, Mich.,...

February 1, 2023, 12:00 pm

Respirerx pharmaceuticals' australian subsidiary inks loan agreements to advance r&d for sleep apnea treatment

RespireRx pharmaceuticals (OTC:RSPI) Inc announced that its recently created Australia-based subsidiary...

February 1, 2023, 9:41 am

Morphosys: negative enterprise value biotech, but lack of near-term catalyst

MorphoSys AG is a German commercial-stage biopharmaceutical company founded in 1992 with more than 100+...

February 1, 2023, 9:21 am

Zentalis pharmaceuticals to participate in two upcoming investor conferences

NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis pharmaceuticals, Inc. (Nasdaq: ZNTL)...

February 1, 2023, 7:01 am

Novo nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts

Danish pharmaceutical company Novo Nordisk AS DK:NOVO.B NVO on Wednesday raised its dividend and launch...

February 1, 2023, 2:25 am


Search within

Pages Search Results: